What is Avatrombopag?
Avatrombopag is an oral medication used to increase platelet counts in individuals with certain medical conditions. It is a thrombopoietin (TPO) receptor agonist, which means it stimulates the production of platelets—components in the blood that help with clotting—by activating the body’s TPO receptors, similar to the natural hormone thrombopoietin.
It is primarily used in patients with:
Chronic liver disease (CLD) who are scheduled to undergo a medical or dental procedure and are at risk of bleeding due to low platelet counts.
Chronic immune thrombocytopenia (ITP) who have had an insufficient response to previous treatments.
Brand Name:
Doptelet®
Pharmacologic Class:
Thrombopoietin receptor agonist (TPO-RA)
Hematopoietic agent
Mechanism of Action:
Avatrombopag works by binding to and activating the thrombopoietin receptor (TPO-R), also known as c-Mpl, which is located on the surface of bone marrow precursor cells. Activation of this receptor stimulates the proliferation and differentiation of megakaryocytes—the cells responsible for producing platelets—ultimately leading to an increase in the number of circulating platelets.
Indications (Uses):
Avatrombopag is FDA-approved for:
Thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure to reduce the need for platelet transfusion.
Chronic immune thrombocytopenia (ITP) in adults who have had an insufficient response to a previous treatment (e.g., corticosteroids, immunoglobulins, splenectomy).
Dosage and Administration:
Dosage depends on the indication:
A. For thrombocytopenia in adults with chronic liver disease:
Patients are stratified based on their baseline platelet count:
• 40 to <50 × 10⁹/L: 60 mg once daily for 5 days
• <40 × 10⁹/L: 40 mg once daily for 5 days
Start dosing 10–13 days before the scheduled procedure
The procedure should occur 5–8 days after the last dose
B. For chronic immune thrombocytopenia (ITP):
Starting dose: 20 mg once daily with food
The dosage may be adjusted based on platelet count, up to a maximum of 40 mg once daily
Daily treatment continues as long as the benefit outweighs the risk
Administration tips:
Take with food to improve absorption
Swallow tablets whole; do not split or crush
Dosage Forms and Strengths:
Oral tablets: 20 mg
Side Effects:
Common side effects:
Headache
Fatigue
Nausea
Fever
Abdominal pain
Edema (swelling)
Less common but serious side effects:
Thromboembolic events (e.g., deep vein thrombosis, pulmonary embolism)
Hepatic decompensation in patients with chronic liver disease
Possible rebound thrombocytopenia after discontinuation
Warnings and Precautions:
Thrombotic risk: Increased platelet counts, especially when exceeding the target, can raise the risk of blood clots. Monitoring is essential.
Liver disease: Use with caution in patients with hepatic impairment; monitor liver function.
Rebound thrombocytopenia: Abrupt discontinuation may lead to dangerously low platelet levels.
Drug Interactions:
Avatrombopag is metabolized primarily by CYP2C9 and CYP3A enzymes:
• Strong CYP2C9 or CYP3A4 inhibitors (e.g., fluconazole) may increase avatrombopag exposure
• Strong inducers (e.g., rifampin) may decrease its effectiveness
Monitor platelet counts and adjust dose if needed when used alongside interacting medications.
Use in Pregnancy and Breastfeeding:
Pregnancy:
There are no adequately controlled studies in pregnant women.
Use only if the potential benefit justifies the potential risk to the fetus.
Lactation:
Unknown if avatrombopag is excreted in human milk.
A decision should be made whether to discontinue breastfeeding or discontinue the drug, considering the mother’s need.
Use in Special Populations:
Renal Impairment: No dose adjustment required.
Hepatic Impairment: Use with caution and monitor closely.
Pediatric Use: Safety and effectiveness in children have not been established.
Monitoring Parameters:
Platelet count: Regular monitoring is essential to avoid excessively high platelet levels.
Liver function: Especially important in CLD patients.
Clinical signs of bleeding or thrombosis.
Storage:
Store at room temperature (20°C to 25°C / 68°F to 77°F)
Keep in original packaging; protect from moisture
Summary:
Avatrombopag (Doptelet) is a thrombopoietin receptor agonist used to increase platelet counts in adults with chronic liver disease undergoing procedures or those with chronic immune thrombocytopenia. It is convenient as an oral tablet and is typically well tolerated. Still, it requires careful monitoring of platelet levels and liver function due to the potential risks of thrombosis and hepatic complications.
FAQ
Q1. Can I get a free sample?
We can send you a samll free sample, and you only need to pay for the shipping cost.
Q2. What is the HyperChem payment term?
T/T in advance
LC at sight
DP at sight
Bank transfer
PayPal
Bitcoin...
Q3. What is HyperChem shipment policy?
Our policy is to strive for the quickest shipment time possible.
For ready stock samples, they are usually shipped within 3 working days after payment received.
For non-ready stock, please contact HyperChem sales team to negotiate.
Q4. What is HyperChem shipment term?
By Express
FedEx UPS DHL EMS
Fast: 3-7 days around, high cost, door to door service
By Air
Suitable for more than 50kg
Fast: 3-7 days, hight cost, port to port, professional broker needed
By Sea
Suitable for more than 500kg
Fast: 7-45 days, low cost, port to port, professional broker needed
We will always attempt to utilize the quickest and most affordable way for customers to receive orders. And follow -up with customers via email for all shipment details as well as updated track information until it arrives without damage.
Q5. What HyperChem will provide after shipment?
For sample orders:
After shipment is done, an timely email including:
1. Track details (Fedex /TNT/DHL/EMS Track number)
2. Packaging photo
3. COA, MSDS, etc
4. Dispatch date & Estimated arriving time
5. Shipping invoice
For commercial orders:
A full set of shipment documents as well as package photos can be provided in scan-copy and original, to help customers complete the customs clearance process.
